In-hospital process for viral hepatitis C screening and management in China (Draft) / 中华肝脏病杂志
Chinese Journal of Hepatology
;
(12): 319-325, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-879638
ABSTRACT
Viral hepatitis C is one of the important causes of liver cirrhosis and hepatocellular carcinoma. There are approximately 10 million cases of chronic hepatitis C virus (HCV) infection in China. However, over 70% of HCV infections of China have not yet been detected. According to the goal of "eliminating viral hepatitis as a public health threat by 2030" of the World Health Organization Viral Hepatitis Strategy, and the fact that medical institutions remain the main places for detecting HCV infections or patients in China at present, we established the " In-hospital process for viral hepatitis C screening and management in China (Draft)", with intention to promote the multidisciplinary collaboration and cooperation among the departments of clinic, laboratory, infection control, management, and etc. in medical institutions, and strengthen consultation and referral of patients with detected HCV antibodies and advance the diagnosis and antiviral treatment of patients with chronic hepatitis C.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
China
/
Hepatitis C
/
Hepacivirus
/
Hepatitis C, Chronic
/
Hospitals
/
Liver Neoplasms
Type of study:
Diagnostic study
/
Screening study
Limits:
Humans
Country/Region as subject:
Asia
Language:
Chinese
Journal:
Chinese Journal of Hepatology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS